SCHEMBL555028

SCHEMBL555028

NCCCC(N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8235057 1.00
SCHEMBL1044479 1.00
SCHEMBL3113278 0.92
SCHEMBL4537329 0.92
SCHEMBL2948865 0.92
SCHEMBL6926014 0.90 GSR (0.43)
SCHEMBL13977639 0.90 GSR (0.43)
Hydrochloric Acid SCHEMBL30379993 0.90 GSR (0.43)
SCHEMBL29012720 0.90 GSR (0.43)
SCHEMBL11778128 0.85 TSHR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035224-A1 Betulin derived compounds as anti-feedants for plant pests VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) 2012-02-09 US claimed
US-20100273801-A1 BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS Valition teknillinen tutikimuskeskus (FI) 2010-10-28 US claimed
US-20100196290-A1 COMPOSITIONS COMPRISING BETULONIC ACID VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) 2010-08-05 US claimed
US-20100190795-A1 BETULIN DERIVED COMPOUNDS USEFUL AS ANTIPROTOZOAL AGENTS VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) 2010-07-29 US claimed
US-20020198254-A1 Polyamide analogs GENELABS TECHNOLOGIES, INC. 2002-12-26 US claimed
US-6468977-B1 COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS APOTEX INC. (CA) 2002-10-22 US claimed
WO-2002062755-A2 POLYAMIDE ANALOGS AS DNA MINOR GROOVE BINDERS GENELABS TECHNOLOGIES, INC. (US) 2002-08-15 WO claimed
WO-2001090095-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 2001-11-29 WO claimed
US-20230265151-A1 GIP/GLP1 CO-AGONIST COMPOUNDS ELI LILLY AND COMPANY 2023-08-24 US disclosed
US-11548975-B2 Isocyanate composition and method for producing isocyanate polymer ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-01-10 US disclosed
US-20210284750-A1 Immunoconjugate Synthesis Method BOLT BIOTHERAPEUTICS, INC. (US) 2021-09-16 US disclosed
US-11001688-B2 Antimicrobial silicone rubber, preparation method therefor and use thereof Suzhou DOBION Medical Technology Co., Ltd. (CN) 2021-05-11 US disclosed
EP-3064501-B1 2-METHYLSULPHANYL-6-NITRO-7-OXO-1, 2, 4-TRIAZOLO [5, 1-C][1, 2, 4]TRIAZINIDE L-ARGININE DIHYDRATE ACTIVE TOWARD WEST NILE VIRUS LIMITED LIABILITY COMPANY URAL CENTER OF BIOPHARMACEUTICAL TECH (RU) 2019-08-21 EP disclosed
US-20190225739-A1 ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER ASAHI KASEI KABUSHIKI KAISHA (JP) 2019-07-25 US disclosed
US-20020198254-A1 Polyamide analogs GENELABS TECHNOLOGIES, INC. 2002-12-26 US disclosed
EP-1259535-A1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-27 EP disclosed
WO-2002072621-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-09-19 WO disclosed
WO-2001060846-A1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-23 WO disclosed
EP-0309971-A2 New spergualin-related compound and pharmaceutical composition ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1989-04-05 EP disclosed
EP-0213571-A2 3-Aminomethyl pyrrol-1-yl-alkyl amines and medicaments containing these compounds BASF Aktiengesellschaft (DE) 1987-03-11 EP disclosed